Showing results (91-100 of 132) with videos related to
Sort By:
Pageof 14
European Journal of Heart Failure|June 22, 2013
Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT studyAnastasia Lesogor, Jay N Cohn, Roberto Latini, et al.European Heart Journal|February 27, 2004
The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFTRoberto Latini, Serge Masson, Inder Anand, et al.Journal of Cardiac Failure|August 4, 2012
Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the African-American heart failure trialAnne L Taylor, Michael L Sabolinski, S William Tam, et al.Clinical Chemistry|June 17, 2006
Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) dataSerge Masson, Roberto Latini, Inder S Anand, et al.JACC. Heart Failure|October 13, 2014
G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFTDennis M McNamara, Anne L Taylor, S William Tam, et al.Journal of Cardiac Failure|December 11, 2007
Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trialLidia Staszewsky, Maylene Wong, Serge Masson, et al.International Journal of Cardiology|December 6, 2005
Chronic heart failure with preserved left ventricular ejection fraction: diagnostic and prognostic value of left atrial sizeAndrea Rossi, Mariantonietta Cicoira, Viorel G Florea, et al.American Heart Journal|May 3, 2005
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)Aldo P Maggioni, Roberto Latini, Peter E Carson, et al.Circulation|December 6, 2011
Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trialsSerge Masson, Inder Anand, Chiara Favero, et al.The New England Journal of Medicine|November 10, 2004
Combination of isosorbide dinitrate and hydralazine in blacks with heart failureAnne L Taylor, Susan Ziesche, Clyde Yancy, et al.Pageof 14